Johns Hopkins University
United States of America
Yassine J. Daoud, M.D., specializes in cataract and refractive surgery (LASIK), as well as the diagnosis and treatment of corneal disorders including Fuchs dystrophy and keratoconus. He is internationally known for his surgical skills especially in complex cornea transplants and management of challenging cataract surgeries. He has special interest in managing complications of previous cataract and cornea surgeries. Dr. Daoud is a highly published author and editor in multiple leading ophthalmology journals. He routinely lectures nationally and internationally. Dr Daoud is the chair of the Wilmer Eye Institute's Femtosecond Laser Assisted Cataract Surgery Committee. He currently leads a group of researchers to improve ocular health and incorporate evolving technologies to improve ocular surgery outcomes. Dr. Daoud received his M.D. degree from Harvard Medical School. He was selected to the prestigious Doris Duke Fellowship where he obtained a clinical research fellowship under the mentorship of the world renowned Dr. C. Stephen Foster at the Massachusetts Eye and Ear Infirmary. He completed an internship at Johns Hopkins Hospital where he was the recipient of the “Best Bedside Skills” Teamwork Award. He completed his ophthalmology residency at Duke University Eye Center and a cornea fellowship at the Wilmer Eye Institute.
Femtosecond laser assisted cataract surgery; DSAEK corneal transplant; Secondary intraocular lens implant
Daoud YJ, Letko E, Nguyen QD, Soukiasian SH, Samson CM, Sangwan V, Harper SL, Michel S, Schuman JS, Foster CS. Aqueous humour outflow facility in OCP. Middle East Journal of Ophthalmology 2004;12:102-107
Sami N, Letko E, Androudi S, Daoud Y, Foster CS, Ahmed AR. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up. Ophthalmology. 2004 Jul; 111(7):1380-2.
Letko E, Miserocchi E, Daoud YJ, Christen W, Foster CS, Ahmed AR. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol. 2004 Jun; 111(3):303-10.